Supply Chain

Unethical practices and forced labor exist in HPMC supply chains. Here’s what can be done about it.

Pharma companies are well accustomed to supply chain issues, but how prepared are they for issues impacting access to medical devices?

Step into a future where science fiction meets reality – the world of cell and gene therapies.

Stu Needleman, Chief Commercial Officer at Piramal Pharma Solutions, discusses the Biosecure Act and other big trends shaking up the industry

Developing science is good; developing successful commercialization strategies is great.

EFPIA signs joint declaration championing open trade in the EU.

Counterfeit medicines pose a significant threat to global health. A recent study uncovers alarming facts and emphasizes the need for solutions.

Experts discuss the trends, challenges, and possibilities of cryopreservation for cell and gene – and how it can freeze time in manufacturing.

It’s time to go back to basics when it comes to pharmaceutical supply chains and preventing shortages.

Experts from Lonza share how biologics and CGT can recognize the gaps and similarities that can be utilized to optimize cell culture media challenges.